Q: What are the early signs and symptoms of liver cancer that individuals should be aware of? Early detection of liver cancer ...

Elafibranor (Iqirvo) was well tolerated and led to sustained improvements in liver enzyme levels and itch severity through 28 weeks in patients with primary sclerosing cholangitis (PSC), according to ...

The liver is a powerhouse of an organ, playing a crucial role in filtering toxins, aiding in digestion and metabolizing drugs. Yet, it’s often an unsung hero, quietly performing its vital functions ...

Your liver is essential for maintaining your body’s overall health — it detoxifies harmful substances, aids digestion, and supports metabolism. However, when your liver isn’t working well, it can ...

A pooled analysis of two phase 3 clinical trials shows that the first-in-class drug improves itching and itching-related ...

Itching without any visible rash is a common but often overlooked symptom of liver disease. This itching, called pruritus, can be very uncomfortable and tends to worsen at night. The cause of this ...

Seladelpar (Livdelzi) provided sustained pruritus relief for up to 30 months in patients with primary biliary cholangitis ...

New safety and efficacy data for primary biliary cholangitis (PBC) treatment Livdelzi (seladelpar) was presented today at The Liver Meeting, hosted by the American Association for the Study of Liver ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new long-term data reinforcing the safety and efficacy profile of ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD), following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE ...

Three-year data from ongoing open-label study supported safety and effectiveness of seladelpar in patients with primary biliary cholangitis.